- Investing Ideas
- Chinese Pharmaceuticals & Biotech High Return On Equity, Low Debt
Chinese Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
3
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
3 companies
Sunshine Guojian Pharmaceutical (Shanghai)
Market Cap: CN¥50.4b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.
688336
CN¥40.15
7D
6.0%
1Y
7.8%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥37.4b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥85.00
7D
6.0%
1Y
-7.4%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥13.2b
Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.
300573
CN¥36.44
7D
0.4%
1Y
4.0%